Inhibitors of protein aggregation
US8263589B2 · kind B2 · utility
7Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 2007 |
| Grant date | Sep 11, 2012 |
| Priority date | — |
| Expiry date | Oct 8, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates generally to the use of diaminophenothiazine compounds to inhibit or reverse the aggregation of synuclein, and for their use in the manufacture of medicaments for this purpose (e.g. for the treatment of Parkinson's Disease). Also provided are related methods of detecting or labelling of aggregated synuclein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.